Most Americans do not use GLP-1s long enough to see meaningful weight-loss owenhaskins Jul 9, 2024 2 min read The largest study to date has reported that despite the explosion in demand for GLP-1s, 58% of patients discontinue use before reaching a clinically meaningful health benefit, according to research by the Blue Cross Blue Shield Association (BCBSA) and conducted by Blue Health Intelligence (BHI)
Patients should not consider berberine as a substitute for prescribed GLP-1 medications
Its important to monitor health regularly and consult with a healthcare provider, especially if using for long-term purposes.
Within the cellular signaling network, Akt promotes mTOR activation, whereas AMPK functions as a negative regulator of mTOR
Systematic reviews of clinical trial data do not identify myalgia as occurring at significantly higher rates in GLP-1-treated patients compared to placebo groups
In a clinical trial, people receiving the treatment are able to adhere to the prescribed regimen through support from study staff and incentives for participation, whereas in a real-world setting people may experience side effects or lose insurance coverage and stop taking their medications, Stokes says
